Table 1.

Patient disposition

	Patients (N = 25)
ITT population, n	25
mITT population, n	25
Patient status at end of infusion 1 interventional phase, n (%)*	25 (100)
Disease progression	22 (88)
Did not progress†	3 (12)
Patient status at end of infusion 2 interventional phase (for patients with second infusion), n (%)*	4 (16)
Disease progression‡	4 (16)

Patients completed the study if they discontinued because of disease progression or death after their last T-cell infusion, or if they were progression-free at the time of study completion (at Sponsor discretion) and moved into long-term follow-up. ITT population: all patients who were enrolled in the trial. mITT population: all patients in the ITT population who received ≥ 1 T-cell infusion.

^*Denominator for percentages is based on the ITT population.

^†Did not progress by the time of the primary analysis; participation was terminated by the study sponsor.

^‡One patient progressed before withdrawing consent.